New study sets baseline for blood clotting in pregnancy to prevent deadly bleeding
NCT ID NCT04753671
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to establish normal blood clotting ranges for healthy pregnant women and new mothers using a new device called Quantra®. Postpartum hemorrhage (heavy bleeding after birth) is a leading cause of maternal death, and knowing what's normal can help doctors detect and treat clotting problems early. Researchers measured clotting in 31 healthy women before and after vaginal or cesarean delivery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY POSTPARTUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hop Jeanne de Flandre Chu Lille
Lille, 59037, France